Anteris Technologies Global (AVR) Cash from Investing Activities (2024 - 2026)
Anteris Technologies Global's (AVR) quarterly Cash from Investing Activities came in at -$182000.0 in Q1 2026, down 116.4% year-on-year from $1.1 million in Q1 2025, and up 54.16% on a QoQ basis from -$397000.0 in Q4 2025.
Anteris Technologies Global (AVR) Cash from Investing Activities (2024 - 2026) Analysis & Trends
Anteris Technologies Global (AVR) has 3 years of Cash from Investing Activities data on file, last reported at -$182000.0 in Q1 2026.
- On a quarterly basis, Cash from Investing Activities fell 116.4% year-over-year to -$182000.0 in Q1 2026; TTM through Mar 2026 was -$1.9 million, a 316.78% decrease from a year earlier, with the FY2025 full-year figure at -$596000.0, up 73.86% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$182000.0, up from -$397000.0 in the prior quarter.
- Over the last five years, Cash from Investing Activities for AVR reached as high as $1.1 million in Q1 2025 and fell as low as -$772000.0 in Q3 2025.
- Historically, Cash from Investing Activities has averaged -$339777.8 across 3 years, with a median of -$537000.0 in 2025.
- Across the five-year window, Cash from Investing Activities soared 254.81% in 2025 and tumbled 116.4% in 2026, its largest moves.
- Year by year, Cash from Investing Activities stood at -$364000.0 in 2024, then dropped by 9.07% to -$397000.0 in 2025, then soared by 54.16% to -$182000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$182000.0 in Q1 2026, -$397000.0 in Q4 2025, and -$772000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.15 Bn | 120.94 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.73 Bn | 43.91 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 32.91 Bn | 31.25 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.79 Bn | 30.55 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.52 Bn | 23.08 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 14.04 Bn | 13.47 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.78 Bn | 13.64 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.04 Bn | 10.98 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Anteris Technologies Global | 684.00 Mn | 684.00 Mn | 380,000.00 | -182,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -182,000.00 |
| Mar 31, 2026 | -182,000.00 |
| Dec 31, 2025 | -397,000.00 |
| Dec 31, 2025 | -397,000.00 |
| Sep 30, 2025 | -772,000.00 |
| Sep 30, 2025 | -772,000.00 |
| Jun 30, 2025 | -537,000.00 |
| Jun 30, 2025 | -537,000.00 |
| Mar 31, 2025 | 1.11 Mn |
| Mar 31, 2025 | 1.11 Mn |
| Dec 31, 2024 | -364,000.00 |
| Dec 31, 2024 | -364,000.00 |
| Sep 30, 2024 | -553,000.00 |
| Sep 30, 2024 | -553,000.00 |
| Jun 30, 2024 | -646,000.00 |
| Jun 30, 2024 | -646,000.00 |
| Mar 31, 2024 | -717,000.00 |
| Mar 31, 2024 | -717,000.00 |